Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Registration NOW open for the Best of ASRM and ESHRE 2025 !

Help us plan ESHRE 2026 - submit your proposals

30 September 2024

We are calling our members to submit their proposals for the invited programme for our 2026 Annual Meeting in London, United Kingdom.

The online application will be open until 23 October 2024.

PGT troubleshooting from intake to follow-up seminar - join the 2024 edition

26 September 2024

This comprehensive seminar will help guide professionals through the different steps of the Preimplantation Genetic Testing (PGT) process, from the initial intake of patients to successful post-procedure follow-up.

Women with premature ovarian insufficiency are at greater risk of severe autoimmune diseases

26 September 2024

Human Reproduction Press Release
Severe autoimmune conditions such Type I diabetes, Addison’s disease, lupus and inflammatory bowel disease, are between two to three times more common in women who have been diagnosed with premature ovarian insufficiency (POI) compared to the general population.

ESGO-ESHRE-ESGE guidelines for fertility-sparing in gynecologic cancer now published

30 August 2024

The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing strategies and follow-up of patients with cervical cancers, ovarian cancers, and borderline ovarian tumours.